Companies you'll love to work for

REGENXBIO
REGENXBIO
regenxbio.com

Locations

United States · Rockville, MD, USA · North America · Washington, DC, USA

industry

Biotechnology

Size

201-1000 employees

Stage

IPO

founded in

2008

REGENXBIO is a leading biotechnology company focused on the development, commercialization, and licensing of recombinant adeno-associated virus (AAV) gene therapy. REGENXBIO's NAV® technology platform, a proprietary AAV gene delivery platform, consists of exclusive rights to more than 100 novel AAV vectors, including AAV7, AAV8, AAV9, and AAVrh10. REGENXBIO's mission is to transform the lives of patients suffering from severe diseases with significant unmet medical need by developing and commercializing in vivo gene therapy products based on REGENXBIO's NAV technology platform. REGENXBIO seeks to accomplish this mission through a combination of internal development efforts and third-party NAV technology platform licensees.

Something looks off?
Open jobs at REGENXBIO

On-site & Remote